explore -WSS

explore

author：entertainment 2025-10-01 00:49:48 - browse：98625

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Medicare details structure of new drug price negotiation program
Next article： Virginia high school admissions case could be legal follow

WSS

Dobbs anniversary: the lost opportunity of abortion as health care

Affirmative action in medical school literally saved lives

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Industry veterans launch new biotech VC with $310M

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Hepatitis C has a cure — but many Americans still lack access to it

explore

explore

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Affirmative action in medical school literally saved lives

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout LOUD podcast: How biotech is using artificial intelligence

The high cost of giving birth even with insurance

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Medical records are filled with copy

Novavax promises a turnaround & Lilly roils the obesity market

Supreme Court strikes down use of affirmative action

How digital tools helped lower hypertension in marginalized patients

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

Readout LOUD podcast: How biotech is using artificial intelligence

Hepatitis C has a cure — but many Americans still lack access to it

Bright Health sells Medicare Advantage business to Molina

Readout LOUD podcast: How biotech is using artificial intelligence

Alkermes shareholders re

focus

entertainment

focus

hotspot